During the past decade, Anders Rosengrentest conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Anders Rosengrentest" #1 collaborator was "Göteborg University" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Anders Rosengrentest" are "Type2 Diabetes" (2 trials). Many other conditions were trialed in "Anders Rosengrentest" in a lesser frequency.

Most popular intervention types in "Anders Rosengrentest" are "Behavioral" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Dapagliflozin" (1 trials), "Lifestyle tool" (1 trials) and "Semaglutide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Anders Rosengrentest" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Anders Rosengrentest". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Anders Rosengrentest, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Anders Rosengrentest, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".